Oncolytics Biotech Stock Technical Analysis
ONC Stock | CAD 1.26 0.01 0.79% |
As of the 4th of December, Oncolytics Biotech holds the Coefficient Of Variation of 5154.38, semi deviation of 3.24, and Risk Adjusted Performance of 0.0234. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Oncolytics Biotech, as well as the relationship between them.
Oncolytics Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Oncolytics, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to OncolyticsOncolytics |
Oncolytics Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Oncolytics Biotech Technical Analysis
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Oncolytics Biotech volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Oncolytics Biotech Trend Analysis
Use this graph to draw trend lines for Oncolytics Biotech. You can use it to identify possible trend reversals for Oncolytics Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Oncolytics Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Oncolytics Biotech Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Oncolytics Biotech applied against its price change over selected period. The best fit line has a slop of 0 , which means Oncolytics Biotech will continue generating value for investors. It has 122 observation points and a regression sum of squares at 0.06, which is the sum of squared deviations for the predicted Oncolytics Biotech price change compared to its average price change.About Oncolytics Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Oncolytics Biotech on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Oncolytics Biotech based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Oncolytics Biotech price pattern first instead of the macroeconomic environment surrounding Oncolytics Biotech. By analyzing Oncolytics Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Oncolytics Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Oncolytics Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Net Debt To EBITDA | 1.02 | 1.52 | Intangibles To Total Assets | 0.0149 | 0.0141 |
Oncolytics Biotech December 4, 2024 Technical Indicators
Most technical analysis of Oncolytics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oncolytics from various momentum indicators to cycle indicators. When you analyze Oncolytics charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | 0.0234 | |||
Market Risk Adjusted Performance | (0.09) | |||
Mean Deviation | 3.31 | |||
Semi Deviation | 3.24 | |||
Downside Deviation | 3.38 | |||
Coefficient Of Variation | 5154.38 | |||
Standard Deviation | 5.29 | |||
Variance | 27.97 | |||
Information Ratio | (0) | |||
Jensen Alpha | 0.1914 | |||
Total Risk Alpha | (0.62) | |||
Sortino Ratio | (0) | |||
Treynor Ratio | (0.1) | |||
Maximum Drawdown | 37.61 | |||
Value At Risk | (5.16) | |||
Potential Upside | 6.47 | |||
Downside Variance | 11.43 | |||
Semi Variance | 10.47 | |||
Expected Short fall | (4.48) | |||
Skewness | 2.84 | |||
Kurtosis | 12.7 |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oncolytics Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Oncolytics Stock, please use our How to Invest in Oncolytics Biotech guide.You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.